Onconetix Inc. Company Profile
NASDAQ: ONCOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 11:17 AM ET
Onconetix at a glance
Onconetix Inc. (NASDAQ: ONCO) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Cincinnati, OH. Onconetix is led by Mr. David Allan White C.A., C.P.A., ICD.D and employs about 2 people. The company's shares have traded publicly since 2022.
At a market capitalization of $3.4 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001782107, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Onconetix do?
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Business description based on the company's public filings.
Company information
- Legal name
- Onconetix Inc.
- Ticker
- NASDAQ: ONCO
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. David Allan White C.A., C.P.A., ICD.D
- Employees
- 2
- Headquarters
- 201 East Fifth Street, Cincinnati, OH, United States
- Phone
- 513 620 4101
- Website
- onconetix.com
- IPO year
- 2022
- Market cap
- $3.43M
- SEC CIK
- 0001782107
- Latest annual report
- 10-K · Mar 13, 2026
Companies similar to Onconetix
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CMNDClearmind Medicine Inc. | 6.60 | +0.01% | $3.35M | vs ONCO |
| SXTP60 Degrees Pharmaceuticals Inc. | 0.95 | -2.31% | $3.34M | vs ONCO |
| DCOYDecoy Therapeutics Inc. | 1.48 | -2.96% | $3.52M | vs ONCO |
| JUNSJupiter Neurosciences Inc. | 2.67 | -3.61% | $3.52M | vs ONCO |
| KAPAKairos Pharma Ltd. | 0.9701 | +1.10% | $3.28M | vs ONCO |
| HCWBHCW Biologics Inc. | 1.60 | +4.58% | $3.58M | vs ONCO |
| APVOAptevo Therapeutics Inc. | 1.80 | -0.27% | $3.25M | vs ONCO |
| CVKDCadrenal Therapeutics Inc. | 0.91 | -2.11% | $3.25M | vs ONCO |